Literature DB >> 28621225

Decreased expression of MGMT in correlation with aberrant DNA methylation in esophageal cancer patients from North India.

Asad Ur Rehman1, Snigdha Saikia2, Mohammad Askandar Iqbal3, Istaq Ahmad1, Afzal Anees4, P S Aravinda5, Pramod Kumar Mishra5, Suresh Hedau6, Sundeep Singh Saluja5, Subhash Medhi2, Syed Akhtar Husain1.   

Abstract

O-6-methylguanine-DNA methyltransferase, DNA repair gene, has been found to be involved with the pathogenesis of the esophageal cancer. DNA hypermethylation and other factors have been suggested to downregulate O-6-methylguanine-DNA methyltransferase. In this communication, the methylation status of O-6-methylguanine-DNA methyltransferase gene and the corresponding O-6-methylguanine-DNA methyltransferase protein expression in esophageal cancer from North India has been studied. In all, 80 samples of tumor tissue along with adjacent normal tissue as controls were analyzed for messenger RNA level of O-6-methylguanine-DNA methyltransferase gene, protein expression, and subcellular localization. The messenger RNA expression was studied using real-time quantitative polymerase chain reaction, protein expression, and its subcellular localization by Western blotting and immunohistochemistry. DNA methylation was assessed through methylation-specific polymerase chain reaction. Clinicopathological parameters were recorded and correlated with the O-6-methylguanine-DNA methyltransferase expression. O-6-methylguanine-DNA methyltransferase messenger RNA expression was found to be downregulated in 65% cases (52/80). The expression of O-6-methylguanine-DNA methyltransferase at the protein level was also found to be absent in 65% (52/80) cases. In all, 52 cases had low or no expression of the protein, whereas out of those 28 remaining cases, 11.25% (09/80) cases had high O-6-methylguanine-DNA methyltransferase protein expression. The absence of O-6-methylguanine-DNA methyltransferase protein coincided with the methylated cases in 84% (38/45), whereas in 07 cases, out of the 45 methylated, O-6-methylguanine-DNA methyltransferase protein was present. The aggressive esophageal cancer patients having methylated O-6-methylguanine-DNA methyltransferase had more than 50% cases with no/mild expression of the O-6-methylguanine-DNA methyltransferase protein ( p > 0.001). Loss of O-6-methylguanine-DNA methyltransferase protein was very frequent in the incidence of esophageal cancer from North Indian patients, and methylation of the promoter region of O-6-methylguanine-DNA methyltransferase was significantly associated in its downregulation.

Entities:  

Keywords:  North India; O-6-methylguanine-DNA methyltransferase; esophageal cancer patients; promoter methylation; protein expression

Mesh:

Substances:

Year:  2017        PMID: 28621225     DOI: 10.1177/1010428317705770

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  3 in total

Review 1.  Epigenetic Alterations in Oesophageal Cancer: Expression and Role of the Involved Enzymes.

Authors:  Nair Lopes; Margareta P Correia; Rui Henrique; Carmen Jerónimo
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

2.  Elevated expression of RUNX3 co-expressing with EZH2 in esophageal cancer patients from India.

Authors:  Asad Ur Rehman; Mohammad Askandar Iqbal; Real Sumayya Abdul Sattar; Snigdha Saikia; Mohammad Kashif; Wasif Mohammad Ali; Subhash Medhi; Sundeep Singh Saluja; Syed Akhtar Husain
Journal:  Cancer Cell Int       Date:  2020-09-10       Impact factor: 5.722

3.  Associations of MGMT promoter hypermethylation with squamous intraepithelial lesion and cervical carcinoma: A meta-analysis.

Authors:  Jin Huang; Jia-You Luo; Hong-Zhuan Tan
Journal:  PLoS One       Date:  2019-10-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.